Illumina Announces Decision to Divest GRAIL
SAN DIEGO, Dec. 17, 2023 /PRNewswire/ — Today, Illumina, Inc. (NASDAQ: ILMN) announced that the company will divest GRAIL.
The divestiture will be executed through a third-party sale or capital markets transaction, consistent with the European Commission’s divestiture order, with the goal of finalizing the terms by the end of the second quarter of 2024.
Related news for (ILMN)
- Illumina advances personalized cancer care with new pharma development partnerships
- Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025
- Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
- Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company’s multiomics strategy
- Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis